Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Butler, Kyle V., Kalin, Jay, Brochier, Camille, Vistoli, Guilio, Langley, Brett, Kozikowski, Alan P.·2010·Journal of the American Chemical Society

Cited by (902)

Items 601–700 of 902

  1. Synthesis of 1-indolyl-3,5,8-substituted γ-carbolines: one-pot solvent-free protocol and biological evaluation
    Premansh Dudhe, Mena Asha Krishnan, Kratika Yadav, Diptendu Roy, Krishnan Venkatasubbaiah, Biswarup Pathak, Venkatesh Chelvam · 2021 · Beilstein Journal of Organic Chemistry
  2. Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
    Antonio Valencia, Veronica L. Reinhart Bieber, Bekim Bajrami, Galina Marsh, Stefan Hamann, Ru Wei, Karen Ling, Frank Rigo, H. Moore Arnold, Olga Golonzhka et al. · 2021 · Frontiers in Neurology
  3. CTCF acetylation at lysine 20 is required for the early cardiac mesoderm differentiation of embryonic stem cells
    Shixin Gong, Gongcheng Hu, Rong Guo, Jie Zhang, Yiqi Yang, Binrui Ji, Gang Li, Hongjie Yao · 2022 · Cell Regeneration
  4. Novel nuclear role of HDAC6 in prognosis and therapeutic target for colorectal cancer
    Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto, Maciej A. Kaliszczak, Miaomiao He, Miguel Ángel Burguillos, Rajaa El Bekay, Vahitha B. Abdul‐Salam, Combiz Khozoie, Khalid Shah, Kevin O’Neill et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Inhibition of HDAC6 elicits anticancer effects on head and neck cancer cells through Sp1/SOD3/MKP1 signaling axis to downregulate ERK phosphorylation
    Rukhsana Kausar, Nga Thi Thanh Nguyen, Truc Phan Hoang Le, Jae Hyung Kim, Sang Yoon Lee · 2025 · Cellular Signalling
  6. Histone deacetylase 6 inhibits STING-dependent antiviral immunity via site-specific deacetylation
    Min Qu, Dali Wei, Qunhua Ke, Pengyuan Cheng, Yiyuan Ma, Berihun Afera, Ke Guo, Miaomiao Li, Xiangping Yin, Xiangwei Wang et al. · 2025 · Journal of Biological Chemistry
  7. Endogenous expression of inactive lysine deacetylases reveals deacetylation-dependent cellular mechanisms
    Tasha B. Toro, Elena Skripnikova, Kiara E. Bornes, Kun Zhang, Terry J. Watt · 2023 · PLoS ONE
  8. Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma
    Tsutomu Anraku, Masaki Murata, Hiroo Kuroki, Akira Kazama, Yuko Shirono, Masayuki Tasaki, Vladimir N. Bilim, Yoshihiko Tomita · 2024 · Journal of Personalized Medicine
  9. Development and Validation of High-Content Analysis for Screening HDAC6-Selective Inhibitors
    Yunhong Nong, Yanyan Hou, Yuting Pu, Si Li, Yan Lan · 2021 · SLAS DISCOVERY
  10. The Role of Epigenetic Mechanisms in Autoimmune, Neurodegenerative, Cardiovascular, and Imprinting Disorders
    Kunal Nepali, Jing‐Ping Liou, Ram Sharma, Sachin Sharma, Amandeep Thakur, Arshdeep Singh, Jagjeet Singh · 2022 · Mini-Reviews in Medicinal Chemistry
  11. Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold
    Bin Wang, Youcai Liu, Lejing Zhang, Yajuan Wang, Zhaoxi Li, Xin Chen · 2023 · Molecules
  12. Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma
    Pranita Atri, Ashu Shah, Gopalakrishnan Natarajan, Satyanarayana Rachagani, Sanchita Rauth, Koelina Ganguly, Joseph Carmicheal, Dario Ghersi, Jesse L. Cox, Lynette M. Smith et al. · 2024 · npj Precision Oncology
  13. Effects of E/Z Configuration of Fluoroalkene-containing HDAC Inhibitors on Selectivity for HDAC Isoforms
    Yoshiro Chuman, Mariko Ueyama, Satoshi Sano, Fei Wu, Yuhei Kiyota, Takayoshi Higashi, Satoshi Osada, Kazuyasu Sakaguchi · 2013 · Chemistry Letters
  14. Exploring hydroxamic acid inhibitors of HDAC1 and HDAC2 using small molecule tools and molecular or homology modelling
    Lydia Daniel, Michael P. Gotsbacher, Tomas Richardson‐Sanchez, William Tieu, Rachel Codd · 2019 · Bioorganic & Medicinal Chemistry Letters
  15. Synthesis of Indoline‐Based Benzhydroxamic Acids as Potential HDAC6 Inhibitors
    Yves Depetter, Silke Geurs, Jorick Franceus, Damijan Knez, Tom Desmet, Karolien De Bosscher, Olivier De Wever, Stanislav Gobec, Matthias D’hooghe · 2019 · ChemistrySelect
  16. Mechanistic Exploration of Methionine 274 Acting as a “Switch” of the Selective Pocket Involved in HDAC8 Inhibition: An in Silico Study
    Yao Peng, Qiushuang Gao, Ying Wang, Qizheng Yao, Ji Zhang · 2021 · ChemMedChem
  17. In silico design of HDAC6 inhibitors with neuroprotective effects
    Yudibeth Sixto‐López, José Antonio Gómez-Vidal, Nuria de Pedro, Martiniano Bello, Martha Cecilia Rosales‐Hernández, José Correa‐Basurto · 2021 · Journal of Biomolecular Structure and Dynamics
  18. Effect of histone deacetylase on prostate carcinoma.
    Yuanfeng Zhang, Qingchun Xu, Guoyuan Liu, Hong Huang, Weiqiang Lin, Yueying Huang, Zepai Chi, Shi‐Lu Chen, Kaijian Lan, Jiahua Lin et al. · 2015 · PubMed Central
  19. Changes in histone lysine acetylation, but not DNA methylation during facultative hibernation in Syrian hamster liver
    Marloes M. Oosterhof, Louis Coussement, Alienke van Pijkeren, Marcel Kwiatkowski, Martijn R. H. Zwinderman, Frank J. Dekker, Tim De Meyer, Vera A. Reitsema, Rainer Bischoff, Victor Guryev et al. · 2024 · Epigenetics Communications
  20. Design, synthesis, and biological evaluation of phenylsulfonylfuroxan-β-carboline-hydroxamic acid ternary hybrids for cancer
    Chao Gao, Wanning Wang, Yongbo Yu, Jianhui Wu · 2025 · European Journal of Medicinal Chemistry
  21. Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases
    Kathrin Tan, M. Mercedes Rodríguez-Fernández, Tim Keuler, Finn K. Hansen, Michael Gütschow, Günther Weindl, Jose Luis Marco · 2025 · Journal of Medicinal Chemistry
  22. Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors
    Linda Schäker‐Hübner, Finn K. Hansen · 2026 · ACS Pharmacology & Translational Science
  23. Bridging protein quality control and epigenetic dysregulation: The HDAC6 paradox in neurological disorders and therapeutic targeting
    Yuhan Chen, Yutong Wu, Xiong Liu, Jiali Wan, Mi Shen, Qi Zhang · 2026 · European Journal of Pharmacology
  24. In-Cell Testing of Zinc-Dependent Histone Deacetylase Inhibitors in the Presence of Class-Selective Fluorogenic Substrates: Potential and Limitations of the Method
    Alla A. Kleymenova, Anastasia S. Zemskaya, Sergey N. Kochetkov, Maxim V. Kozlov · 2024 · Biomedicines
  25. Repurposing of known drugs from multiple libraries to identify novel and potential selective inhibitors of HDAC6 via in silico approach and molecular modeling
    Naz Mina Mert Şahin, Buse Erdogan, Kemal Yelekçi · 2024 · Heliyon
  26. Unlocking the potential of histone deacetylase inhibitors in combatting age-related retinal degenerative diseases
    Bo Liu, Minglu Wang, Ning Pu, Jiale Wang, Wenhui Fan, Chengkang Qu, Hao Wu, Zongming Song, Ye Tao · 2025 · Ageing Research Reviews
  27. Hydroxamic Acids as Histone Deacetylase Inhibitors
    Florian Thaler, Vaishali Manikrao Patil, Satya P. Gupta · 2013 · Springer eBooks
  28. Genistein attenuates LPS-induced inflammatory injury of rat dorsal root ganglion neuron via down-regulating HDAC6.
    Songlin Zhou, Junqing Huang, Ke Li, Shuaigang DU, Bin Yang, Zhonghua Guo · 2022 · PubMed Central
  29. HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice
    Jiayin Zhao, Yongtao He, Yufei Duan, Yuanyuan Ma, Hongtian Dong, Xiaoshuang Zhang, Rong Fang, Yunhe Zhang, Mei Yu, Fang Huang · 2023 · International Journal of Molecular Sciences
  30. Activation of angiotensin II type 2 receptor leads to preservation of primary cilia in tubular cells during renal ischaemia‐reperfusion injury
    Tomás Rivabella Maknis, María Fernanda Fussi, Alejandro Pedro Pariani, Victoria Huhn, Rodrigo Vena, Cristián Favre, Sara María Molinas, Maria Cecilia Larocca · 2024 · The Journal of Physiology
  31. Design, Synthesis, and Structural Evaluation of Acetylated Phenylthioketone Inhibitors of HDAC10
    Juana Goulart Stollmaier, Paris R. Watson, David W. Christianson · 2024 · ACS Medicinal Chemistry Letters
  32. The α-Tubulin Deacetylase HDAC6 in Aggresome Formation and Autophagy
    Christiane Richter‐Landsberg · 2015 · Elsevier eBooks
  33. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance
    Jin Yang, Yan‐Cheng Yu, Zixuan Wang, Qing-Qing Li, Ning Ding, Xuejiao Leng, Jiao Cai, Mengyuan Zhang, Jingjing Wang, Yun Zhou et al. · 2024 · European Journal of Medicinal Chemistry
  34. Novel Mannich Bases Derived from 2-Substituted Benzimidazole and (Thio)Hydantoin Moieties as Potent Histone Deacetylase 6 (HDAC6) Inhibitors
    Reda El‐Sayed Mansour, Hanan Gaber Abdulwahab, Hend M. A. El-Sehrawi · 2021 · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences
  35. Cytoskeletal Functions, Defects, and Dysfunctions Affecting Human Fertilization and Embryo Development
    Heide Schatten, Qing‐Yuan Sun · 2016 · Human Reproduction
  36. LRRK2-mediated phosphorylation of HDAC6 regulates HDAC6-cytoplasmic dynein interaction and aggresome formation
    Richard M. Lucas, Claudia S. Bauer, Kavitha Chinnaiya, Aurélie Schwartzentruber, Ruby MacDonald, Mark O. Collins, Jan Olav Aasly, Gunnar Brønstad, Laura Ferraiuolo, Heather Mortiboys et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Inhibitors of the Zinc‐Dependent Histone Deacetylases
    Helle M. E. Kristensen, Andreas S. Madsen, Christian Adam Olsen · 2019 · Methods and principles in medicinal chemistry
  38. Augmentation of Histone Deacetylase 6 Activity Impairs Mitochondrial Respiratory Complex I in Ischemic/Reperfused Diabetic Hearts
    Shelley L. Baumgardt, Juan Fang, Xuebin Fu, Yanan Liu, Zhengyuan Xia, Ming Zhao, Ling Chen, Rachana Mishra, Muthukumar Gunasekaran, Progyaparamita Saha et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  39. MAP3K4 signaling regulates HDAC6 and TRAF4 coexpression and stabilization in trophoblast stem cells
    Hannah A. Nelson, Nathan A. Mullins, Amy N. Abell · 2024 · Journal of Biological Chemistry
  40. HDAC6 Inhibition Drives Synaptic Protein Acetylation and Enhances Long-Term Memory in Mice
    S.P. Rivas, Laura Esquivel, Julia Busso, Angeles Salles, María Krawczyk, Melina Sol Alvarez, María Florencia Acutain, María Verónica Báez, Mariano Martín Boccia, Ramiro Freudenthal · 2025 · Molecular Neurobiology
  41. A Highly Selective, Cell-Permeable Fluorescent Probe for Imaging Histone Deacetylase 6 in Live Cells
    Văn Thắng Nguyễn, Tanja Koenen, Jonas Bucevičius, Gražvydas Lukinavičius · 2026 · Journal of the American Chemical Society
  42. Indole Scaffolds in Neurological Therapeutics: Synthesis, Structure- Activity Relationships and Drug-Receptor Interactions
    Alisha Bano, Ahsan Ahmed Khan, Shom Prakash Kushwaha, Aleena -, Syed Mehdi Hasan Zaidi, S. S. Hasan, Asiya Fatima · 2026 · Mini-Reviews in Medicinal Chemistry
  43. Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases
    Abhay Kumar Singh, Yemgadda Goutham Sudhan, Sudharshanam Lakshmi Chandana, Ashok Iyaswamy, Siva Sundara Kumar Durairajan · 2026 · Springer eBooks
  44. Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studies
    Simona Barone, Ivana Bello, Gessica Filocamo, Carmen Cerchia, Anna Guadagni, Mirko Brunetti, Emanuela G. Cosentino, Maria Hanl, Beate König, Camilla Esposito et al. · 2026 · European Journal of Medicinal Chemistry
  45. Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery
    Jun-Jie Wang, Ya Gao, Xin-Qian Ji, Jia-Yi Yin, Meng‐zhi Zhang, Bo Wang, Huimin Liu, Siqi Feng, Ning Wang, Guo‐Liang Lu et al. · 2026 · Medicinal Research Reviews
  46. Enantioconvergent iso-Pictet-Spengler Reactions: Organocatalytic Synthesis of Chiral Tetrahydro-γ-carbolines
    William R. Cassels, Jennifer L. Fulton, Jeffrey S. Johnson · 2023 · Organic Letters
  47. HDAC6 inhibitor promotes reactive oxygen species ‐meditated clearance of Staphylococcus aureus in macrophage
    Maimaitiaili Yimiti, Xuefeng Fei, Hao Yang, Xiaobao Yang, Shuhui Li, Huxidanmu Tuoheniyazi, Danping Liu, Junrui Ma, Jialing Xie, Juanjuan Zheng et al. · 2024 · Clinical and Experimental Pharmacology and Physiology
  48. Abolished clustering of MeCP2T158M can be partially reverted with small molecules
    Rodrigo Lata, Liesbeth Steegmans, Ranie Kellens, Marnik Nijs, Hugo Klaassen, Matthias Versele, Frauke Christ, Zeger Debyser · 2024 · Translational Medicine Communications
  49. Epigenetic Tools in Chronic Pain Studies
    Guang Bai, Ke Ren · 2018 · Elsevier eBooks
  50. Design, synthesis, and histone deacetylase inhibition study of novel 4‐(2‐aminoethyl) phenol derivatives
    Runesh Podili, KM Abha Mishra, Ashish Sunil Akkewar, Sanjay Kumar, V. V. S. Prasanna Kumari Rayala, Uttam Kulhari, Bidya Dhar Sahu, Pullapanthula Radhakrishnanand, Kalyan Kumar Sethi · 2023 · Journal of Biochemical and Molecular Toxicology
  51. Synthesis of fluorinated tubastatin A derivatives with bi-, tri-, and tetracyclic cap groups: molecular docking with HDAC6 and evaluation of in vitro antitumor activity
    Huaxin Luo, Zheng Huang, Xiangdong Mo, Chunmei Long, Kaiyuan Wang, Rong Deng, Xiao‐Feng Zhu, Zhuo Zeng · 2025 · RSC Medicinal Chemistry
  52. Novel computational biology methods and their applications to drug discovery
    Sharangdhar S. Phatak, Hoang T. Tran, Shuxing Zhang · 2011 · Frontiers in Biology
  53. Design, Synthesis, and Biological Evaluation of New Urushiol Derivatives as Potent Class I Histone Deacetylase Inhibitors
    Hao Zhou, Zhiwen Qi, Danyang Liu, Xingyin Xue, Chengzhang Wang · 2023 · ChemBioChem
  54. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Inhibitors of Neuroblastoma Cell Colony Growth That Increase Lysosome Accumulation
    Daniel Herp, Johannes Ridinger, Dina Robaa, Stephen A. Shinsky, Karin Schmidtkunz, Talha Z. Yesiloglu, Theresa Bayer, Peter A. Sehr, Nikolas Gunkel, Aubry K. Miller et al. · 2020 · ChemRxiv
  55. Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases
    Jose Luis Marco, Daniel Diez‐Iriepa, Mireia Toledano‐Pinedo, Alicia Porro, Pedro Almendros, M. Mercedes Rodríguez‐Fernández, Abdelouahid Samadi, Isabel Iriepa, Francisco Javier Lopez-Munoz, Aizpea Artetxe-Zurutuza et al. · 2023 · ChemRxiv
  56. Septins Enable T Cell Contact Guidance via Amoeboid-Mesenchymal Switch
    Alexander S. Zhovmer, Alexis Manning, Chynna Smith, Jian Wang, Xuefei Ma, Denis Tsygankov, Nikolay V. Dokholyan, Alexander X. Cartagena‐Rivera, Rakesh K. Singh, Erdem D. Tabdanov · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Endosymbiosis in trypanosomatids: The bacterium division depends on microtubule dynamism
    Júlia Ribeiro Moraes, Azuil Barrinha, Luan Santana Gonçalves de Lima, Juliana Cunha Vidal, Carolina Moura Costa Catta‐Preta, Wanderley de Souza, Aline Araújo Zuma, María Cristina M. Motta · 2024 · Experimental Cell Research
  58. Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions
    Sonu Rajput, Sumeet Kumar Singh, Poonam Yadav, Amit Khurana, Ralf Weiskirchen, Umashanker Navik · 2026 · Military Medical Research
  59. Mitochondrial fission mediates an evolutionarily conserved antibacterial defense response
    Ronan Kapétanovic, Syeda Farhana Afroz, James E. B. Curson, Ina Kirmes, Divya Ramnath, Stephan Nothjunge, Jinting Liu, Jordan D. Atkinson, Arnaud Ahier, Karoline D. Raven et al. · 2026 · Science Immunology
  60. Visible-light-mediated radical cascade sulfonylation/trifluoromethylation/difluoromethylation of activated alkenes with sulfinates towards γ-carbolinone derivatives
    Yu-cai Tang, Jiale Liu, Qiumei Yin, Jianhua Shi, Weiming Xia, Jiaming Huang, Hongxing Ma, Beibei Shan, Yuan-Dao Chen, Wei-Min He · 2026 · Organic Chemistry Frontiers
  61. Effects of entinostat, quisinostat, and tubastatin-A on alcohol consumption in male high ethanol consuming rats
    Sheketha R. Hauser, Laura B. Ferguson, Tiebing Liang, Erin Jarvis, Roy Dayne Mayfield, Richard L. Bell · 2025 · Frontiers in Epigenetics and Epigenomics
  62. Nucleocytoplasmic HDAC Inhibition Drives Acetylation-dependent TDP-43 Mislocalization and Disulfide-linked Oligomerization
    Nataliia Lukianenko, Dong Min Kang, Aybuke Bekci, Yun Kyung Kim, Sungsu Lim · 2025 · Journal of Molecular Biology
  63. Design and evaluation of highly selective histone deacetylase 6 inhibitors derived from the natural product tryptoline
    Khan Hashim Ali, Chiranjeev Sharma, Yong Jin Oh, J. Yu, Soong‐Hyun Kim, Hee-jin Lee, Young Ho Seo · 2025 · Molecular Pharmacology
  64. Design, synthesis, and biological evaluation of quinazolin-4-one-based selective HDAC6 inhibitors targeting serine 531, histidine 614 residues, and the L1 and L2 loop
    Sunil Gupta, Yong Jin Oh, Mi Kyung Kim, Eunyoung Ha, Young Ho Seo · 2025 · European Journal of Medicinal Chemistry
  65. Pharmacological landscape of carbolines: a holistic view
    Yao Zhang, Fule Wu, Muneeb Ur Rehman, Sihui Long · 2026 · RSC Medicinal Chemistry
  66. Synthesis and uranyl(VI) extraction performance of a calix[4]pyrrole–tetrahydroxamic acid receptor
    Sara Karnib, Rana Baydoun, Wissam R. Zaidan, Nancy AlHaddad, Omar El Samad, B. Nsouli, Francine Cazier, Pierre-Édouard Danjou · 2026 · Beilstein Journal of Organic Chemistry
  67. Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors
    Irina Honin, Zora Nováková, Felix Feller, Simon Schneider, Linda Schäker‐Hübner, Cyril Bařinka, Finn K. Hansen · 2026 · International Journal of Molecular Sciences
  68. Design, Synthesis, and Biological Evaluation of Novel Triazine‐Based Dual Histone Deacetylase/phosphatidylinositol 3‐kinase Inhibitors for Breast Cancer Therapy
    Lara Luzietti, Gustavo Salgado Pires, Ana Ryan, Crisamie Regidor, Matthew Hiller, Danilo Sarti, Tríona Ní Chonghaile, Pedro de Sena Murteira Pinheiro, Damir Varešlija, Daniel Alencar Rodrigues · 2026 · ChemMedChem
  69. Thiazole-Linked N -Hydroxypropanamide Derivatives: Selective HDAC6 Inhibitors with Therapeutic Potential for Neurodegenerative Diseases
    Gibeom Nam, Jun Min Jung, Seyun Yang, Da Eun Kim, Pulla Reddy Boggu, Cheolhee Kim, E J Kim, Chanhee Jo, Hyun-Mo Yang, Jihun Kim et al. · 2026 · Journal of Medicinal Chemistry
  70. Prognostic, diagnostic and therapeutic value of the cancer tubulin code
    Carolina Vilela, Daniela Gomes-Andrade, Sonia de Regules Silva, Hélder Maiato · 2026 · Cancer and Metastasis Reviews
  71. Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders
    Mikhail Tsymliakov, Maria Hanl, Jana Enns, Shiyang Zhai, Eleonora Ferretti, Philipp König, Rama Kousa, Jia‐Wey Tu, Christian Steinebach, Michael Gütschow et al. · 2026 · Journal of Medicinal Chemistry
  72. Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity
    Abdelrahman A. F. Elsayed, Jianqiu Zhang, Alvan Febrian Shalas, Petra E. van der Wouden, Donald J. M. van Pinxteren, Willem Jespers, Frank J. Dekker · 2026 · Journal of Medicinal Chemistry
  73. Identification of TgElp3 as an essential, tail-anchored mitochondrial lysine acetyltransferase in the protozoan pathogen toxoplasma gondii
    Krista L. Stilger · 2014
  74. Quantifying Small Molecule-Induced Changes in Cellular Protein Expression and Posttranslational Modifications Using Isobaric Mass Tags
    Isabelle Becher, Maria Fälth Savitski, Marcus Bantscheff · 2014 · Methods in molecular biology
  75. Synthesis and Biological Evaluation of Targeted Transcriptional Activator with HDAC8 Inhibitory Activity
    Abhijit Saha · 2018 · Springer theses
  76. Novel Radiotracer Development Poster Abstracts
    2012 · Journal of Cerebral Blood Flow & Metabolism
  77. Tetrahydro-β-carboline scaffold in drug discovery
    Xin Chen · 2023 · Elsevier eBooks
  78. Synthesis of New Fluorinated Tubastatin A Derivatives Based on Cyclopentane/Cyclohexane with Good Anti‐tumor Activity in Vitro
    Xiangdong Mo, Yinbo Liu, Xiaofeng Mo, Huaxin Luo, Majeed Irfan, Rong Deng, Xiao‐Feng Zhu, Hui Wang, Zhuo Zeng · 2024 · ChemistrySelect
  79. Design, synthesis and biological evaluation of novel selective thiol-based histone deacetylase(HDAC) VI inhibitors bearing indeno[1,2-c]pyrazole or benzoindazole scaffold
    Qihao Xu, Shujia Yu, Yijun Cai, Jinyu Yang, Linxiang Zhao, Dan Liu · 2018 · Chemical Research in Chinese Universities
  80. Futuristic Approaches Towards Designing of Isozyme-Selective Histone Deacetylase Inhibitors Against Zinc-Dependent Histone Deacetylases
    Shabir Ahmad Ganai · 2020 · Springer eBooks
  81. Elucidating the Roles of Fenton Reactants in Drug‐Treated Cells by Using a Selective Rhodamine‐Thiophenol Fluorogenic Sensor
    Zhanlong Wang, Jia Hao Yeo, Elizabeth J. New · 2021 · Analysis & Sensing
  82. HDAC6, une désacétylase très spécifique porteuse d’espoir thérapeutique
    Alexis Osseni, Laurent Schaeffer · 2022 · médecine/sciences
  83. Protective effects of histone deacetylase 6 specific inhibitor tubastatin A on subarachnoid hemorrhage in rats and the underlying mechanisms.
    Yuwei Zhu, Haiping Zheng, Chunli Chen · 2023 · PubMed Central
  84. Role of HDAC6 in Transcription Factor EB Mediated Clearance of Misfolded Proteins in Chronic Kidney Disease
    Angela S. Brijmohan · 2017 · TSpace (University of Toronto)
  85. MiRNAs and tumor suppressors form a gene regulatory network to protect multiciliogenesis
    Merit Wildung · 2019
  86. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Inhibitors of Neuroblastoma Cell Colony Growth That Increase Lysosome Accumulation
    Daniel Herp, Johannes Ridinger, Dina Robaa, Stephen A. Shinsky, Karin Schmidtkunz, Talha Z. Yesiloglu, Theresa Bayer, Peter A. Sehr, Nikolas Gunkel, Aubry K. Miller et al. · 2020 · ChemRxiv
  87. Contilisant+Belinostat hybrids, as new multi-target-directed polyfunctionalized indole derivatives able to inhibit histone deacetylase/cholinesterase/monoamine oxidase enzymes, and modulate histamine 3/sigma 1/5-HT6/dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases
    Mireia Toledano‐Pinedo, Alicia Porro, Saray Macaulet, Pedro Almendros, Isabel Iriepa, M. Mercedes Rodríguez‐Fernández, Francisco Javier Lopez-Munoz, Aizpea Artetxe-Zurutuza, Ander Matheu, Jose Luis Marco · 2023 · ChemRxiv
  88. Medicinal Chemistry in the Context of the Human Genome
    Andreas Brunschweiger, Jonathan Hall · 2013 · Methods and principles in medicinal chemistry
  89. Histone Deacetylase 6 (HDAC6) Is Critical for Tumor Cell Survival and Promotes the Pro-Survival Activity of 14-3-3ζ viaDeacetylation of Lysines Within the14-3-3ζ Binding Pocket
    Jeffrey B. Mortenson · 2015 · ScholarsArchive (Brigham Young University)
  90. Function and Regulation of the Tip60-p400 Complex in Embryonic Stem Cells: A Dissertation
    Poshen B. Chen · 2015 · eScholarship@UMassChan
  91. Einfluss der Histon Deacetylase 6 auf den Glucocorticoid Rezeptor-vermittelten Glucosestoffwechsel
    Robin Winkler · 2012 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  92. Elucidation of the Histone Deacetylase 6 Pharmacophore
    Jay H. Kalin · 2012 · Figshare
  93. MOLECULAR ADAPTATION TO ANTI-CANCER CHEMOTHERAPY IN LEUKEMIA
    Eric I. Zimmerman · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  94. Mechanisms underlying the neuroprotective effects of histone deacetylase inhibitors
    Benjamin S. Durham · 2015 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  95. Evaluation of inhibitors of histone deacetylases as potential neurotrophic agents
    Surabhi Shukla, I Muhammad, LA Walker, BL Tekwani · 2014 · Planta Medica
  96. Evaluation of Photoreactive and Phenothiazine-based HDAC Inhibitors
    Antonett Madriaga · 2014 · Figshare
  97. Epigenetic and Nongenomic Roles for Histone Deacetylases in Heart Failure
    Weston W. Blakeslee, Philip D. Tatman, Timothy A. McKinsey · 2016 · Cardiac and vascular biology
  98. Studies Towards Broadening The Substrate Profile And Regulation Of Histone Deacetylase 1
    Dhanusha A. Nalawansha · 2016 · Human Biology
  99. Targeting proteostasis in atrial fibrillation
    Zhang De-li · 2015
  100. [Histone deacetylase 6: structure, functions and development of selective inhibitors].
    Renshuai Liu, Hao Fang · 2015 · PubMed